The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma
Abstract Background Epithelioid sarcoma is a rare soft tissue sarcoma characterized by SMARCB1/INI1 deficiency. Much attention has been paid to the selective EZH2 inhibitor tazemetostat, where other systemic treatments are generally ignored. To explore alternative treatment options, we studied the e...
Sparad:
| Huvudupphov: | , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2024-02-01
|
| Serie: | BMC Cancer |
| Ämnen: | |
| Länkar: | https://doi.org/10.1186/s12885-024-11921-7 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|